Date: Sunday, October 21, 2018
Session Type: ACR Poster Session A
Session Time: 9:00AM-11:00AM
To define the clinical phenotype of myositis patients with anti-U1- ribonucleoprotein (RNP) autoantibodies.
The clinical features of 20 anti-U1RNP-positive patients were assessed and compared to those of 132 antisynthetase syndrome (ASyS), 178 dermatomyositis (DM), and 135 immune-mediated necrotizing myopathy (IMNM) patients.
Twenty (4.6%) of 437 patients tested were anti-U1-RNP-positive; these were younger (~37 years) and more likely to be black (60%) than ASyS, DM, or IMNM patients. Muscle weakness, arthritis, interstitial lung disease (ILD), and DM-specific skin features eventually developed in 80%, 60%, 45%, and 60% of anti-U1-RNP-positive patients, respectively. Four of 7 (57%) anti-U1-RNP-positive patients had a necrotizing muscle biopsy. ILD was more severe in anti-U1-RNP-positive patients than in DM or IMNM. Glomerulonephritis and pericarditis occurred in 25% and 40% of anti-U1-RNP-positive patients, respectively, but rarely in the other groups. Pulmonary hypertension (PH) developed in 25% of anti-U1-RNP-positive, 20% of ASyS, and in <3% of DM and IMNM patients. Interestingly, glomerulonephritis, pericarditis and PH only occurred in anti-U1- RNP-positive patients with co-existing anti-Ro52 autoantibodies.
Muscle weakness and arthritis are the most common clinical features in anti- U1-RNP-positive patients; when present, ILD is severe. Pericarditis, glomerulonephritis and PH are relatively common in anti-U1-RNP-positive patients, and only developed in those anti-U1-RNP-positive patients with co-existing anti-Ro52 autoantibodies.
To cite this abstract in AMA style:Casal-Dominguez M, Pinal-Fernandez I, Corse A, Paik JJ, Albayda J, Casciola-Rosen L, Johnson C, Danoff SK, Christopher-Stine L, Tiniakou E, Mammen A. Myositis Patients with Anti-U1-RNP and Anti-Ro52 Autoantibodies Are at Risk of Pericarditis, Glomerulonephritis, and Pulmonary Hypertension [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 10). https://acrabstracts.org/abstract/myositis-patients-with-anti-u1-rnp-and-anti-ro52-autoantibodies-are-at-risk-of-pericarditis-glomerulonephritis-and-pulmonary-hypertension/. Accessed September 22, 2021.
« Back to 2018 ACR/ARHP Annual Meeting
ACR Meeting Abstracts - https://acrabstracts.org/abstract/myositis-patients-with-anti-u1-rnp-and-anti-ro52-autoantibodies-are-at-risk-of-pericarditis-glomerulonephritis-and-pulmonary-hypertension/